Anemia Neonatal
7
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants
Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery
Alteration of Stool Microbiota in Preterm Infants With Anemia
Influence of Umbilical Cord Clamping Time in the Newborn
Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia
The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants
Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates